A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2006
12/06/2006	EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof
12/06/2006	EP1430304B1 Method for diagnosing chronic inflammatory bowel diseases
12/06/2006	EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen
12/06/2006	EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/06/2006	EP1117685B1 Treatment of inflammatory disease
12/06/2006	EP1078001B1 Il-6 antagonist peptides
12/06/2006	EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases
12/06/2006	EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells
12/06/2006	EP0956042B1 Mycosis vaccines
12/06/2006	EP0910406B1 Recombinant canine herpesviruses
12/06/2006	EP0688362B1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
12/06/2006	CN1875032A Biological active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine
12/06/2006	CN1874996A Aminopropanol derivatives
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006	CN1874785A Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals
12/06/2006	CN1874771A Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions
12/06/2006	CN1872997A New technique for culturing stem cells (carrying therapy gene) of human's xenogenic stromata in large-scale
12/06/2006	CN1872873A Function of cytoinhibition peptide for treating rheumatoid arthritis
12/06/2006	CN1872857A Reverse-turn mimetics and method relating thereto
12/06/2006	CN1872856A Reverse-turn mimetics and method relating thereto
12/06/2006	CN1872344A Gene therapy method of stem cell (carrying therapy gene) of human xenogenic stroma
12/06/2006	CN1872306A Preparation of Chinese traditional medicine for treating baby's cough, and preparation method
12/06/2006	CN1872280A Composition of Chinese traditional medicine for treating allergic rhinitis, and preparation method
12/06/2006	CN1872179A Microspheres in use for injection of Chinese traditional medicine of containing astragalus root, and preparation method
12/06/2006	CN1872155A Microspheres in use for injection of astragalus root and red sage root, and preparation method
12/06/2006	CN1872141A Liquor for improving function of human immunity
12/06/2006	CN1872137A Drop pills of total glycoside of Jiaogulan, and preparation method
12/06/2006	CN1872115A Microspheres for injecting gen-seng injection and preparation method
12/06/2006	CN1872095A Drop pills of enhancing body immunity and fighting against senium
12/06/2006	CN1872071A Medication for enhancing body immunity, and fighting against senium, and preparation method
12/06/2006	CN1872058A Medication composition of containing macrolides
12/06/2006	CN1872051A Dry suspensoid of ginkgolide, and preparation method
12/06/2006	CN1872041A Medicine use of 3 ú¿3 nitryl 4 hydroxyú®- ethyl acrylate controlled xanthine oxidase
12/06/2006	CN1288170C Sulphatization derivative of polysaccharide, its preparation method and use
12/06/2006	CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/06/2006	CN1287769C Dispersible phospholipid stabilzed microparticles
12/06/2006	CN1287680C Oral immunostimulation of mammals, birds, fish and reptiles from 1-4 linked ss-d-mannuronic acid
12/05/2006	USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006	US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006	US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006	US7144871 Partial and full agonists of A1 adenosine receptors
12/05/2006	US7144569 Mutant gliadin protein whose wild-type sequence can be modified by transglutaminase; fusion protein comprising a non-gliadin sequence; kit comprising antibody to interferon- gamma detects recognition by T-cell
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2387531C Purine derivatives
12/05/2006	CA2334711C Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies
12/05/2006	CA2293713C Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/05/2006	CA2146429C 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
11/2006
11/30/2006	WO2006126581A1 Combination drug
11/30/2006	WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006125963A2 Modified leukocyte ig-like receptor family members (lir' s) with increased affinity for class i mhc and their uses in modulating t cell activation
11/30/2006	WO2006125930A1 Composition for the treatment of multiple sclerosis
11/30/2006	WO2006125921A2 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	WO2006125807A1 Thiazole derivatives and use thereof
11/30/2006	WO2006125803A1 Thiazole derivatives and use thereof
11/30/2006	WO2006125784A1 Tricyclic spiro derivatives as crth2 modulators
11/30/2006	WO2006125665A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis
11/30/2006	WO2006109186A3 Early endosome neutralising compouds as vaccine adjuvants
11/30/2006	WO2006098603A3 Composition comprising isoorientin for suppressing histamine
11/30/2006	WO2005070965A3 Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases
11/30/2006	WO2004047728A3 Compositions and methods for the treatment of immune related diseases
11/30/2006	US20060270839 Crystallization of IGF-1
11/30/2006	US20060270740 Prostaglandin derivatives
11/30/2006	US20060270730 Histone deacetylase inhibitors as immunosuppressants
11/30/2006	US20060270717 Therapeutic combination
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270676 Hydrazono-malonitriles
11/30/2006	US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060270646 Jnk inhibitors
11/30/2006	US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006	US20060270009 Oxidation resistance; from hesperidin using Aspergillus fermentation
11/30/2006	US20060269632 Remedies for allergic diseases and process for producing the same
11/30/2006	US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia
11/30/2006	US20060269593 Pretreatment by applying to skin; transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a systemic or mucosol antibody response
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
11/30/2006	US20060269547 Humanized anti-CD3 specific antibodies
11/30/2006	US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006	DE202006014919U1 Composition, useful for promoting bladder health and stabilizing immunosystems, comprises an extract Vaccinium macrocarpon, L-ascorbic acid, zinc and selenium
11/30/2006	CA2610357A1 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	CA2609447A1 Polypeptides
11/30/2006	CA2609369A1 Composition for the treatment of multiple sclerosis
11/30/2006	CA2608153A1 Thiazole derivatives for use as p13k modulators
11/30/2006	CA2608143A1 Thiazole derivatives and use thereof
11/30/2006	CA2602965A1 Tricyclic spiro derivatives as crth2 modulators
11/30/2006	CA2545557A1 Stromal antigen-presenting cells and use thereof
11/29/2006	EP1726310A1 Medicine for cancer therapy
11/29/2006	EP1725556A1 Hiv integrase inhibitors
11/29/2006	EP1725553A1 Tetrahydropyridoindole derivatives
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725519A1 Amino acid derivatives
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725256A1 A vaccine formulated for administration to mucosa of the lungs
11/29/2006	EP1725248A1 Preparations containing echinacea extracts and thiocyanate

1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1172